Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide

Author(s):  Zur Eyal

Issue:  Jul/Aug 2012 - Volume 16, Number 4
View All Articles in Issue

Page(s):  288-293

Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 1
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 2
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 3
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 4
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 5
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide Page 6

Download in electronic PDF format for $75

Abstract:  Eosinophilic esophagitis is a clinicopathologic disease isolated to the esophagus. It is caused by immunologic reactions to ingested and inhaled allergans. Symptoms include regurgitation, vomiting, pain, anorexia, and dysphagia. Endoscopy with biopsy is currently the only reliable diagnostic test for eosinophilic esophagitis. The disease should remit with treatments of dietary exclusion, topical corticosteroids, or both. Oral viscous budesonide is one of the promising options of topical corticosteroid to treat eosinophilic esophagitis. Since there are no commercial medicines of oral viscous budesonide, it is solely a compounded medication. This article briefly discusses the properties of the disease and covers a few compounding possibilities to oral viscous budesonide.

Related Keywords: eosinophilic esophagitis, esophagus, immunologic reaction, allergens, dietary restrictions, topical administration, oral gel, viscous budesonide, topical corticosteroid, steroid gel, formulation

Related Categories: EAR NOSE THROAT, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Eosinophilic Esophagitis: Treatment with Oral Viscous Budesonide
Zur Eyal
Jul/Aug 2012
Pg. 288-293

Current Topical Treatments in Wound Healing - Part 1
Helmke Christopher D
Jul/Aug 2004
Pg. 269-274

Budesonide 0.0.25% Mucoadhesive Gel
Allen Loyd V Jr
Jul/Aug 2021
Pg. 323

Oral Viscous Sucralfate Gel for Post-procedural Treatment of Barrett's Esophagus
Zur Eyal
Sep/Oct 2019
Pg. 376-381

Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice
, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017
Pg. 322-329

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
May/Jun 2015
Pg. 243

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Sensitization Therapy for Warts
Kuntz Rachael
Jul/Aug 2003
Pg. 266-270

Novel Approaches to Topical Psoriasis Therapy
Koyama Gregory
, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Sep/Oct 2015
Pg. 357-365

Budesonide 1-mg//10-mL Mucolox Oral Suspensions
Allen Loyd V Jr
Jul/Aug 2018
Pg. 317

Case Report: Topical Gel for the Treatment of a Refractory Leg Ulcer
Israel Alan
May/Jun 2003
Pg. 176-178

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Women's Oral Health: Is There a Hormonal Link?
Preckshot John
Jan/Feb 2004
Pg. 10-14

Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Klemmer Anja
, Krämer Irene, Kamin Wolfgang
May/Jun 2013
Pg. 254-261

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
Sep/Oct 2024
Pg. 400

Lidocaine Hydrochloride 2% Viscous Oral Topical Solution
Allen Loyd V Jr
Nov/Dec 2024
Pg. 486

Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Curcumin 2% Topical Gel
Allen Loyd V Jr
Nov/Dec 2022
Pg. 509

Anhydrous Silicon Base Topical Gel Vehicle
Allen Loyd V Jr
May/Jun 2018
Pg. 232

Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Zur Eyal
Sep/Oct 2019
Pg. 366-375

Return to Top